平安医药及医疗器械创新ETF(516820)资产负债表
| |
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
13,388,182.54 |
| 结算备付金 |
33,797,299.75 |
30,557,586.40 |
521,251.05 |
1,569,579.64 |
| 存出保证金 |
297,179.87 |
158,438.54 |
345,726.11 |
273,494.78 |
| 交易性金融资产 |
1,621,320,466.14 |
1,107,601,416.89 |
1,198,671,862.00 |
1,188,537,682.47 |
| 其中：股票投资 |
1,621,320,466.14 |
1,107,601,416.89 |
1,198,671,862.00 |
1,188,537,682.47 |
| 债券投资 |
- |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
- |
565,209.35 |
412,631.96 |
608,614.54 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
314,174.02 |
- |
54,500.00 |
| 应收申购款 |
- |
- |
- |
- |
| 其他资产 |
91,049.16 |
1,392,566.78 |
37,753.68 |
194,380.98 |
| 资产总计 |
1,667,958,675.74 |
1,175,621,502.08 |
1,229,278,744.74 |
1,204,626,434.95 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
3,873,615.92 |
- |
- |
884.08 |
| 应付赎回款 |
- |
- |
- |
- |
| 应付管理人报酬 |
733,156.39 |
476,788.52 |
515,436.72 |
487,170.25 |
| 应付托管费 |
146,631.29 |
95,357.70 |
103,087.34 |
97,434.03 |
| 应付销售服务费 |
- |
- |
- |
- |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
6,349.87 |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
2,641,262.66 |
3,357,204.46 |
3,001,880.31 |
3,243,867.14 |
| 负债合计 |
7,394,666.26 |
3,935,700.55 |
3,620,404.37 |
3,829,355.50 |
| 所有者权益 |
| 实收基金 |
4,953,415,249.00 |
3,777,415,249.00 |
2,990,415,249.00 |
2,920,415,249.00 |
| 未分配利润 |
-3,292,851,239.52 |
-2,605,729,447.47 |
-1,764,756,908.63 |
-1,719,618,169.55 |
| 所有者权益合计 |
1,660,564,009.48 |
1,171,685,801.53 |
1,225,658,340.37 |
1,200,797,079.45 |
| 负债及所有者权益总计 |
1,667,958,675.74 |
1,175,621,502.08 |
1,229,278,744.74 |
1,204,626,434.95 |
微信公众号
证券之星APP
基本资料
